WBCs, LN, Spleen, Thymus Flashcards

1
Q

Clinically significant neutropenia (<500/mm3)

A

Agranulocytosis (most commonly caused by drug toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rare type of leukocytosis indicative of myeloproliferative disorder

A

Basophilic leukocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Seen in LN when there is predominant humoral response

A

Follicular hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Seen in LN when there is predominant cell-mediated response

A

Paracortical hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Two main parts of a LN

A

Cortex and medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Seen in LN follicles

A

B cells (CD 20; secondary follicles are stimulated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Seen in LN paracortex

A

T cells (CD3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Three areas of a secondary LN follicle

A

Germinal center, mantle zone, marginal zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cells seen in the dark zone of a secondary follicular LN germinal center

A

Centroblast (BCD - blasta, centro, dark zone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Morphology of LN wherein there is increase in size and number of cells lining lymphatic sinusoids

A

Sinus histiocytosis (usually seen in malignancies, but nonspecific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common cancer in children

A

ALL (acute lymphoblastic leukemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Two types of ALL

A

Pre B-cell ALL (more common, 85%) and pre T-cell ALL (not good! generally T cell involvement is more difficult to treat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Notable mutations associated with B-cell ALL

A

t(12;21) and t(9;22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Notable mutations associated with T-cell ALL

A

NOTCH-1 (70%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Unique metastatic site of ALL

A

CNS (meningeal spread) and testis (sanctuary site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Kind of ALL seen more in early childhood

A

B-cell ALL (vs T-cell ALL which is in adolescence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Neoplastic proliferation of myeloid precursors

A

AML (acute myeloid leukemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

AML with best prognosis

A

Acute promyelocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AML with very poor prognosis

A

Therapy-related AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diagnostic cut-off of myeloblasts in bone marrow for AML

A

> = 20% myeloblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Absence of blasts in peripheral blood

A

Aleukemic leukemia (seen in AML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Genetic mutation of APML

A

t(15;17) vs B-cell ALL (t12:21 and t9:22) and T-cell ALL (NOTCH-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Seen in APML, needle-like azurophilic granules

A

Auer rods inside faggot cells (faggots love rods and DICs, kasi APML is associated with DIC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

APML is curable in 80% of cases using this substance

A

All-trans retinoic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Age of onset of AML
Generally adults, while ALL more common in children
26
Most common leukemia of adults in the Western world
CLL (chronic myelogenous leukemia) or SML (small lymphocytic lymphoma)
27
Only difference between CLL and SML
Peripheral blood lymphocytosis (>5000 in CLL, < 5000 in SML)
28
Seen in PBS of CLL/SML
Small lymphocytes with smudge cells
29
Notable sequelae of CLL/SML
Richter syndrome (progression to diffuse large B-cell lymphoma)
30
Genetic mutation seen in CML
BCR-ABL t(9;22), the Philadelphia chromosome
31
Result of BCR-ABL t(9;22) Philadelphia chromosome mutation
Preferential proliferation of granulocytic and megakaryocytic lines
32
Parameters for diagnosis of CML
WBC >100000 and thrombocytosis, blasts <10% in peripheral blood
33
Clinical phases of CML
Chronic, accelerated, blast (can "transform" into AML)
34
Common treatment modality between ALL and CML due to BCR-ABL t(9;22)
Tyrosine kinase inhibitor (imatinib / Gleevec)
35
Solid focus of leukemia outside bone marrow seen in blast crisis of CML
Chloroma
36
Distinguishes CML from leukemoid reaction
Leukocyte alkaline phosphatase (LAP); high LAP means reactive process, low LAP is malignant
37
LN involvement of Hodgkin's lymphoma
Single, axial group of nodes (cervical, mediastinal, paraaortic) (with contiguous spread, less aggressive)
38
LN involvement of Non-Hodgkin's lymphoma
Multiple, peripheral nodes (with non contiguous spread, more aggressive)
39
Characteristic cell seen in Hodgkin's lymphoma
Reed-Sternberg cells
40
Two pathologic microscopic features of Hodgkin's lymphoma
Reed-Sternberg cells and mixed inflammatory cell infiltrate (T-cells, eosinophils, histiocytes + inflammatory background)
41
Five subtypes of Hodgkin's lymphoma
Nodular sclerosis (most common), mixed cellularity, lymphocyte rich, lymphocyte depleted, lymphocyte predominant (mostly reactive B cells, compared to others with T cells)
42
Subtypes of Hodgkin's associated with EBV
Mixed cellularity and lymphocyte depleted (more aggressive)
43
Markers used in Hodgkin's lymphoma (can stain Reed-Sternberg cells)
CD15 and CD30
44
Marker used for lymphocyte predominant Hodgkin's that can stain B-cells
CD20
45
Most common subtype of Hodgkin's
Nodular sclerosis
46
Subtype of Hodgkin's associated with HIV
Lymphocyte depleted (+ B cell lymphoma + Kaposi's sarcoma)
47
Subtypes of non-Hodgkin's B-cell lymphomas
Follicular, diffuse large B-cell, Burkitt's, marginal zone
48
Most common indolent lymphoma of adulthood
Follicular lymphoma
49
Notable mutation associated with follicular lymphoma
BCL2 (anti-apoptotic)/t(14;18) Follicular FOURTEEN
50
Most common form of non-Hodgkin's and most common lymphoma of adults
Diffuse large B-cell lymphoma (anaplastic, aggressive, rapidly fatal without treatment)
51
IHC stains used for diffuse large B-cell lymphoma
CD45 (lymphoid), CK (epithelial), and vimentin (mesenchymal)
52
Three types of Burkitt's lymphoma
Endemic, sporadic, HIV-associated
53
The fastest growing human tumor
Burkitt's lymphoma
54
Features that would favor a neoplastic follicle
Increase in desnity of follicles, size, and number; more uniform appearance; attenuation of mantle zones; follicles in perinodal fat
55
Type of Burkitt's associated with EBV
Endemic (100%)
56
Notable mutation associated with Burkitt's
MYC t(8;14) / Burk-EIGHT
57
Histologic finding of Burkitt's lymphoma
Starry sky pattern
58
Cell of origin of marginal zone lymphoma
Memory B-cell (arises from tissues in chronic inflammation like salivary glands in Sjogren, thyroid in Hashimoto's, stomach in gastritis) / sore memories that become cancer
59
T-cell non-Hodgkin's lymphoma
Mycosis fungoides or cutaneous T-cell lymphoma
60
Cells found in mycosis fungoides or cutaneous T-cell lymphoma
Sezary cells (T cells with cerebriform nuclei, causing Pautrier microabscesses)
61
Occurs in mycosis fungoides
Sezary syndrome (generalized exfoliative erythroderma with leukemia of Sezary cells)
62
Most important plasma cell neoplasm
Multiple myeloma
63
Pathophysiology behind multiple myeloma
Production of monoclonal immunoglobulin (M protein) vs polyclonal Ig production if reactive
64
Two PAS (+) findings in MM
Russell bodies (cytoplasmic) and Dutcher bodies (nuclear)
65
Renal finding in MM
Bence Jones proteinuria (Ig light chain)
66
Disorder of defective hematopoietic maturation with increased risk of transformation to AML
MDS
67
Cellular morphology found in MDS
Ringed sideroblasts (erythroid), granulocytic (pseudo-pelget Huet cells), Pawn ball megakaryocytes
68
Chronic myeloproliferative disorders asociated with JAK2 mutations
Polycythemia vera, essential thrombocytosis, primary myelofibrosis (BCR-ABL for CML; all responsive to tyrosine-kinase)
69
Paraneoplastic syndrome associated with thymomas
MG, PRCA, other autoimmune diseases